4,187
Views
87
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

, , , , , , , , , , , , & show all
Pages 24-34 | Received 21 Jul 2009, Accepted 18 Sep 2009, Published online: 26 Jan 2010

References

  • Heuts EM, van der Ent FWC, von Meyenfeldt MF, Voogd AC. Internal mammary lymph drainage and sentinel node biopsy in breast cancer – A study on 1008 patients. Eur J Surg Oncol 2008.
  • Farrús B, Vidal-Sicart S, Velasco M, Zanón G, Fernández PL, Muñoz M, . Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys 2004; 60:715–21.
  • Turner-Warwick RT. The lymphatics of the breast. Br J Surg 1959; 46:574–82.
  • Veronesi U, Arnone P, Veronesi P, Galimberti V, Luini A, Rotmensz N, . The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 2008;19:1553–60.
  • Freedman GM, Fowble BL, Nicolaou N, Sigurdson ER, Torosian MH, Boraas MC, . Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 2000;46:805–14.
  • Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999;35:1320–5.
  • Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, . Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: Analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 2008;107:379–87.
  • Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: Diagnosis and implications for patient management – a systematic review. J Clin Oncol 2008;26:4981–9.
  • Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, . Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353(9165):1641–8.
  • Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, . Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949–55.
  • Musat E, Poortmans P, Van den Bogaert W, Struikmans H, Fourquet A, Bartelink H, . Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes. Eur J Cancer 2007;43:718–24.
  • Lievens Y, Poortmans P, Van den Bogaert W. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer. Radiother Oncol 2001;60:257–65.
  • Poortmans P, Kouloulias V, van Tienhoven G, Collette L, Struikmans H, Venselaar JLM, . Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works. Strahlenther Onkol 2006;182:576–82.
  • Poortmans P, Kouloulias VE, Venselaar JL, Struikmans H, Davis JB, Huyskens D, . Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I–III breast cancer: The individual case review. Eur J Cancer 2003;39:2035–42.
  • Poortmans PM, Venselaar JL, Struikmans H, Hurkmans CW, Davis JB, Huyskens D, . The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: A quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I–III breast cancer (1). Int J Radiat Oncol Biol Phys 2001;49:1399–408.
  • Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, . Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956–62.
  • Prosnitz RG, Hubbs JL, Evans ES, Zhou S-M, Yu X, Blazing MA, . Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment. Cancer 2007;110:1840–50.
  • Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Møller H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer 2007;7:9.
  • Taylor CW, McGale P, Povall JM, Thomas E, Kumar S, Dodwell D, . Estimating cardiac exposure from breast cancer radiotherapy in clinical practice. Int J Radiat Oncol Biol Phys 2008.
  • Harris EE. Cardiac mortality and morbidity after breast cancer treatment. Cancer Control 2008;15:120–9.
  • Bird BRJH, Swain SM. Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems. Clin Cancer Res 2008;14:14–24.
  • Taylor CW, Povall JM, McGale P, Nisbet A, Dodwell D, Smith JT, . Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys 2008;72:501–7.
  • Senkus-Konefka E, Jassem J. Cardiovascular effects of breast cancer radiotherapy. Cancer Treat Rev 2007;33:578–93.
  • Doyle JJ, Neugut AI, Jacobson JS, Wang J, McBride R, Grann A, . Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys 2007;68:82–93.
  • Correa CR, Litt HI, Hwang W-T, Ferrari VA, Solin LJ, Harris EE. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol 2007;25:3031–7.
  • Hooning MJ, Botma A, Aleman BMP, Baaijens MHA, Bartelink H, Klijn JGM, . Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007;99:365–75.
  • Harris EER, Correa C, Hwang W-T, Liao J, Litt HI, Ferrari VA, . Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 2006;24:4100–6.
  • Patt DA, Goodwin JS, Kuo Y-F, Freeman JL, Zhang DD, Buchholz TA, . Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 2005;23:7475–82.
  • Prosnitz RG, Chen YH, Marks LB. Cardiac toxicity following thoracic radiation. Semin Oncol 2005;32(2 Suppl 3):S71–S80.
  • Katayama N, Sato S, Katsui K, Takemoto M, Tsuda T, Yoshida A, . Analysis of factors associated with radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy. Int J Radiat Oncol Biol Phys 2008.
  • Krengli M, Sacco M, Loi G, Masini L, Ferrante D, Gambaro G, . Pulmonary changes after radiotherapy for conservative treatment of breast cancer: A prospective study. Int J Radiat Oncol Biol Phys 2008;70:1460–7.
  • Lind P. Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation. Acta Oncol 2006;45:13–5.
  • Muren LP, Maurstad G, Hafslund R, Anker G, Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 2002;62:173–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.